Download MendeleyStructure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence.
Furet, P., Salem, B., Mesrouze, Y., Schmelzle, T., Lewis, I., Kallen, J., Chene, P.(2019) Bioorg Med Chem Lett 29: 2316-2319
- PubMed: 31235263
- DOI: https://doi.org/10.1016/j.bmcl.2019.06.022
- Primary Citation of Related Structures:
6Q2X, 6Q36 - PubMed Abstract:
The YAP-TEAD protein-protein interaction is a potential therapeutic target to treat cancers in which the Hippo signaling pathway is deregulated. However, the extremely large surface of interaction between the two proteins presents a formidable challenge for a small molecule interaction disrupter approach. We have accomplished progress towards showing the feasibility of this approach by the identification of a 15-mer peptide able to potently (nanomolar range) disrupt the YAP-TEAD interaction by targeting only one of the two important sites of interaction. This peptide, incorporating non-natural amino acids selected by structure-based design, is derived from the Ω-loop sequence 85-99 of YAP.
Organizational Affiliation:
Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland. Electronic address: pascal.furet@novartis.com.
